These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29641559)

  • 1. DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    Zhou JJ; Wang YM; Lee VWS; Zhang GY; Medbury H; Williams H; Wang Y; Tan TK; Harris DCH; Alexander SI; Durkan AM
    PLoS One; 2018; 13(4):e0195657. PubMed ID: 29641559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
    Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
    Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration.
    Zhou JJ; Wang YM; Lee VW; Phoon RK; Zhang GY; Wang Y; Tan TK; Hu M; Wang LD; Saito M; Sawyer A; Harris DC; Alexander SI; Durkan AM
    Int J Clin Exp Med; 2012; 5(1):24-33. PubMed ID: 22328945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
    Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
    Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression.
    Bonacina F; Martini E; Svecla M; Nour J; Cremonesi M; Beretta G; Moregola A; Pellegatta F; Zampoleri V; Catapano AL; Kallikourdis M; Norata GD
    Cardiovasc Res; 2021 Jul; 117(9):2069-2082. PubMed ID: 32931583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
    Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
    Front Immunol; 2018; 9():2212. PubMed ID: 30319653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.
    Johnson TS; Mahnke K; Storn V; Schönfeld K; Ring S; Nettelbeck DM; Haisma HJ; Le Gall F; Kontermann RE; Enk AH
    Clin Cancer Res; 2008 Dec; 14(24):8169-77. PubMed ID: 19088032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
    Tenbusch M; Nchinda G; Storcksdieck genannt Bonsmann M; Temchura V; Überla K
    Int Immunol; 2013 Apr; 25(4):247-58. PubMed ID: 23184617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal expression of DEC-205 targeted allergen alleviates an asthmatic phenotype in mice.
    Maaske A; Devos FC; Niezold T; Lapuente D; Tannapfel A; Vanoirbeek JA; Überla K; Peters M; Tenbusch M
    J Control Release; 2016 Sep; 237():14-22. PubMed ID: 27374625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
    Zhang H; Guo C; Zhang A; Fan Y; Gu T; Wu D; Sparatore A; Wang C
    Eur J Pharmacol; 2012 Dec; 697(1-3):106-16. PubMed ID: 23085268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation.
    Rowinska Z; Koeppel TA; Sanati M; Schelzig H; Jankowski J; Weber C; Zernecke A; Liehn EA
    PLoS One; 2017; 12(2):e0170644. PubMed ID: 28234900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.
    Njongmeta LM; Bray J; Davies CJ; Davis WC; Howard CJ; Hope JC; Palmer GH; Brown WC; Mwangi W
    Vaccine; 2012 Feb; 30(9):1624-35. PubMed ID: 22240344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants.
    Sartorius R; Bettua C; D'Apice L; Caivano A; Trovato M; Russo D; Zanoni I; Granucci F; Mascolo D; Barba P; Del Pozzo G; De Berardinis P
    Eur J Immunol; 2011 Sep; 41(9):2573-84. PubMed ID: 21688262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response.
    Fossum E; Tesfaye DY; Bobic S; Gudjonsson A; Braathen R; Lahoud MH; Caminschi I; Bogen B
    J Immunol; 2020 Aug; 205(3):661-673. PubMed ID: 32591401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; de Vos P; Bixel MG; Vestweber D; van Berkel TJ; Kuiper J
    Cardiovasc Res; 2008 Jun; 78(3):590-6. PubMed ID: 18250143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with trifunctional nanoparticles that address CD8
    Shen L; Krauthäuser S; Fischer K; Hobernik D; Abassi Y; Dzionek A; Nikolaev A; Voltz N; Diken M; Krummen M; Montermann E; Tubbe I; Lorenz S; Strand D; Schild H; Grabbe S; Bros M
    Nanomedicine (Lond); 2016 Oct; 11(20):2647-2662. PubMed ID: 27628310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
    Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
    Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.